Solstein Capital, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Solstein Capital, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2022$79,000
-1.2%
1,8130.0%0.05%
+8.3%
Q4 2021$80,000
+15.9%
1,8130.0%0.05%
+20.0%
Q3 2021$69,000
+3350.0%
1,813
+4116.3%
0.04%
+1900.0%
Q2 2021$2,000
-98.3%
43
-98.6%
0.00%
-99.3%
Q3 2020$120,000
-7.7%
3,1790.0%0.27%
-12.9%
Q2 2020$130,000
+8.3%
3,1790.0%0.31%
-33.1%
Q1 2020$120,0003,1790.46%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2021
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 668,200$30,717,0009.01%
Camber Capital Management LP 1,200,000$55,164,0005.18%
Camber Capital Management LP 1,000,000$45,970,0004.32%
Gary Goldberg Planning Services Inc 178,496$8,205,0003.41%
Hamlin Capital Management, LLC 1,217,870$55,985,0003.36%
Winch Advisory Services, LLC 109,101$5,015,0003.22%
NORTHROAD CAPITAL MANAGEMENT LLC 151,701$6,974,0002.69%
Reynders McVeigh Capital Management, LLC 296,118$13,613,0002.59%
SALEM CAPITAL MANAGEMENT INC 120,520$5,540,0002.58%
Keystone Financial Planning, Inc. 74,338$3,417,0002.58%
View complete list of GLAXOSMITHKLINE PLC shareholders